Skip to main content
OpenTrials
Completed

NCT Number: NCT04967638

Survival Analysis of Oral Cancer Patients

This study aims to assess the survival rate of oral squamous cell carcinoma (OSCC) patients following immediate mandibular reconstruction with vascularized fibula flap (VFF) and to identify risk factors influencing the overall survival rate and postoperative outcomes.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–90 year

Sex eligibility

All sexes

Study type

Observational

Primary location

UZ Leuven

Leuven, Belgium

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Clinical diagnosis of stage IV OSCC
  • Follow-up period more than one year.

Exclusion criteria

  • Non-neoplastic diseases
  • Two-staged reconstruction
  • Presurgical distant metastasis

Treatment and study plan

tumor resection and mandible reconstruction

Procedure

The patients who underwent primary ablative tumor resection with segmental mandibulectomy and immediate VFF reconstruction were retrieved from the database

Primary outcomes

  1. The overall cumulative survival

    Time frame: 5th year

    The overall cumulative survival was recorded at the fifth-year.

Sponsors and collaborators

Lead sponsor

KU Leuven

Other

Registry information

Official study title

Survival Analysis of Segmental Mandibulectomy With Immediate Vascularized Fibula Flap Reconstruction in Stage IV Oral Squamous Cell Carcinoma Patients

Important dates

Study start
2020
Primary completion
2020
Study completion
2020
First posted
Jul 19, 2021
Registry last updated
Jul 19, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.